Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says [Yahoo! Finance Canada]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance Canada
company as part of the U.S. ?drugmaker's strategic simplification, according to an analyst note on Monday. Baum, who joined Pfizer in 2024, will transition into the role of senior strategic ?advisor to ?CEO Albert Bourla before fully exiting the company by the end of ?this year, according to a BMO Capital Markets note. The drugmaker and Baum were not immediately ?available for ?comment when contacted ?by Reuters. "This move ?is likely reflective of continued operational simplification at the company rather than a major strategic shift," BMO analysts said. Baum was a long-time analyst at Citi, where he served as ?head of global healthcare and ?managing director of equity ?research, before joining ?Pfizer. Prior to his role ?at Citi, Baum covered European ?pharmaceuticals at ?Morgan Stanley. He will still be involved in helping manage the company's higher-level strategy ?but less ?involved in the day-to-day operations, the note ?said. (Reporting by Kunal Das in Bengaluru; ?E
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says [Yahoo! Finance]Yahoo! Finance
- After her cancer misdiagnosis, Lucy Liu advocates for early screening [USA TODAY]USA TODAY
- Pfizer (PFE) had its "underperform" rating reaffirmed by Royal Bank Of Canada. They now have a $25.00 price target on the stock.MarketBeat
- U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility [Yahoo! Finance]Yahoo! Finance
- U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility [TheStreet.com]TheStreet.com
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 4/17/26 - Form 4
- 4/16/26 - Form 4
- 4/10/26 - Form 3
- PFE's page on the SEC website